Abstract:Objective: Vascular invasion (VI) profoundly impacts the prognosis of hepatocellular carcinoma (HCC), yet the underlying biomarkers and mechanisms remain elusive. This study aimed to identify prognostic biomarkers for HCC patients with VI. Methods: Transcriptome data from primary HCC tissues and HCC tissues with VI were obtained through the Genome Expression Omnibus database. Differentially expressed genes (DEGs) in the two types of tissues were analyzed using functional enrichment analysis to evaluate their biological functions. We examined the correlation between DEGs and prognosis by combining HCC transcriptome data and clinical information from The Cancer Genome Atlas database. Univariate and multivariate Cox regression analyses, along with the least absolute shrinkage and selection operator (LASSO) method were utilized to develop a prognostic model. The effectiveness of the model was assessed through time-dependent receiver operating characteristic (ROC) curve, calibration diagram, and decision curve analysis. Results: In the GSE20017 and GSE5093 datasets, a total of 83 DEGs were identified. Gene Ontology analysis indicated that these DEGs were predominantly associated with xenobiotic stimulus, collagen-containing extracellular matrix, and oxygen binding. Additionally, Kyoto Encyclopedia of Genes and Genomes analysis revealed that the DEGs were primarily involved in immune defense and cellular signal transduction. Cox and LASSO regression further identified 7 genes (HSPA8, ABCF2, EAF1, MARCO, EPS8L3, PLA3G1B, C6), which were used to construct a predictive model in the training cohort. We used X-tile software to calculate the optimal cut-off value to stratify HCC patients into low-risk and high-risk groups. Notably, the high-risk group exhibited poorer prognosis than the low-risk group (P < 0.001). The model demonstrated area under the ROC curve (AUC) values of 0.815, 0.730, and 0.710 at 1-year, 3-year, and 5-year intervals in the training cohort, respectively. In the validation cohort, the corresponding AUC values were 0.701, 0.571, and 0.575, respectively. The C-index of the calibration curve for the training and validation cohorts were 0.716 and 0.665. Decision curve analysis revealed the model's efficacy in guiding clinical decision-making. Conclusions: The study indicates that 7 genes may be potential prognostic biomarkers and treatment targets for HCC patients with VI.

Identification Of Two Portal Vein Tumor Thrombosis Associated Proteins In Hepatocellular Carcinoma: Protein Disulfide-Isomerase A6 And Apolipoprotein A-I

[Study of Serum Proteome Biomarkers with Relation to the Formation of Portal Vein Tumor Thrombi in Hepatocellular Carcinoma Patients].

[Screening Low Molecular Weight Protein Biomarkers Relevant to Portal Vein Tumor Thrombi in Serum of Patients with Hepatocellular Carcinoma].

Purification and identification of serum protein biomarkers with relation to portal vein tumor thrombi screened by SELDI-TOF MS

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

Comparative Proteome Analysis of PVTT Related Small Molecules

S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.

Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics

Identification of Serologic Biomarkers for Predicting Microvascular Invasion in Hepatocellular Carcinoma

Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma

Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma

Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance

P0240 : Proteomic Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma

Proteomic Analysis on Metastasis-Associated Proteins of Human Hepatocellular Carcinoma Tissues

Identification of prognostic biomarkers for hepatocellular carcinoma with vascular invasion

The Potential of Plasma Thrombomodulin As a Biomarker of Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

In-depth Proteomic Analysis of Tissue Interstitial Fluid for Hepatocellular Carcinoma Serum Biomarker Discovery

Expression of Platelet-Derived Endothelial Cell Growth Factor and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma